MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 04
18-02-2011

PANK2 20q13, PLA2G6 22q13

Neurodegeneration with brain iron accumulation (NBIA)
Vs. 05
16-09-2011

PANK2 20q13, PLA2G6 22q13

Neurodegeneration with brain iron accumulation (NBIA)
Vs. 06
21-12-2012

PANK2 20q13, PLA2G6 22q13

Neurodegeneration with brain iron accumulation (NBIA)
Vs. 08
24-08-2015

PANK2 20q13, PLA2G6 22q13

Neurodegeneration with brain iron accumulation (NBIA)
Vs. 01
23-07-2008
NF1 17q11.2 Neurofibromatosis
Vs. 02
08-10-2008
NF1 17q11.2 Neurofibromatosis
Vs. 06
01-03-2013
NF1 17q11.2 Neurofibromatosis
Vs. 08
18-11-2016
NF1 17q11.2 Neurofibromatosis
Vs. 09
10-09-2011
TSC1 9q34 Tuberous Sclerosis
Vs. 10
15-02-2012
TSC1 9q34 Tuberous Sclerosis
Vs. 11
03-12-2012
TSC1 9q34 Tuberous Sclerosis
Vs. 12
23-07-2015
TSC1 9q34 Tuberous Sclerosis
Vs. 13
23-02-2016
TSC1 9q34 Tuberous Sclerosis
Vs. C3-01
16-02-2018
TSC1 9q34 Tuberous Sclerosis
Vs. 05
09-09-2008
Mitochondria Mitochondrial DNA (mtDNA)
Vs. 11
26-10-2009
Mitochondria Mitochondrial DNA (mtDNA)
Vs. 14
02-01-2013
Mitochondria Mitochondrial DNA (mtDNA)
Vs. 15
23-07-2015
Mitochondria Mitochondrial DNA (mtDNA)
Vs. 16
18-08-2016
Mitochondria Mitochondrial DNA (mtDNA)
Vs. 02
20-02-2007
   
Vs. 02
20-02-2007
   
Vs. 06
26-04-2010
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 07
20-01-2012
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 09
21-12-2012
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 10
01-03-2013
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 11
01 May 2014
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 12
16-03-2015
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 Cytochrome P-450
Vs. 06
11-03-2009
GJB1 Xq13.1 Charcot Marie Tooth disease, x-linked
Vs. 08
14-02-2010
GJB1 Xq13.1 Charcot Marie Tooth disease, x-linked
Vs. 11
03-12-2012
GJB1 Xq13.1 Charcot Marie Tooth disease, x-linked
Vs. 12
28-04-2014
GJB1 Xq13.1 Charcot Marie Tooth disease, x-linked
Vs. 13
03-02-2016
GJB1 Xq13.1 Charcot Marie Tooth disease, x-linked
Vs. 08
30-01-2009
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 10
16-09-2010
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 12
02-09-2015
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 08
30-01-2009
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 10
16-09-2011
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 12
02-09-2015
CCM 7q21 Cerebral carvernous malformations (CCM)
Vs. 08
11-10-2011
KAL1 Xp22 Kallmann syndrome, x-linked
P132-A2 Vs. 09 13-07-2012 KAL1 Xp22 Kallmann syndrome, x-linked
P132-A2 Vs. 10 03-12-2012 KAL1 Xp22 Kallmann syndrome, x-linked
P132-A2 Vs. 12 09-12-2015 KAL1 Xp22 Kallmann syndrome, x-linked
P132-A2 Vs. 14 01-02-2017 KAL1 Xp22 Kallmann syndrome, x-linked
P132-A3 Vs. A3-01 01-03-2018 KAL1 Xp22 Kallmann syndrome, x-linked
Vs. 07
02-10-2011
FGFR1 8p11.2, GNRHR 8p21, KISSR1 19p13.3, GNRH1, NELF 9q34.3 Kallmann syndrome
Vs. 08
24-11-2011
FGFR1 8p11.2, GNRHR 8p21, KISSR1 19p13.3, GNRH1, NELF 9q34.3 Kallmann syndrome
Vs. 09
21-12-2012
FGFR1 8p11.2, GNRHR 8p21, KISSR1 19p13.3, GNRH1, NELF 9q34.3 Kallmann syndrome
Vs. 11
04-12-2015
FGFR1 8p11.2, GNRHR 8p21, KISSR1 19p13.3, GNRH1, NELF 9q34.3 Kallmann syndrome
Vs. 06
10-06-2008
SLC12A3 16q13 Gitelman syndrome
Vs. 09
16-09-2011
SLC12A3 16q13 Gitelman syndrome
Vs. 10
20-12-2012
SLC12A3 16q13 Gitelman syndrome
Vs. 11
05-06-2014
SLC12A3 16q13 Gitelman syndrome
Vs. 12
21-09-2017
SLC12A3 16q13 Gitelman syndrome
Vs. 10
05-11-2010
SCN1a 2q24.3 Epilepsy
Vs. 11
16-09-2011
SCN1a 2q24.3 Epilepsy
Vs. 12
03-12-2012
SCN1a 2q24.3 Epilepsy
Vs. 13
22-07-2015
SCN1a 2q24.3 Epilepsy
Vs. 14
04-12-2015
SCN1a 2q24.3 Epilepsy
Vs. 15
11-01-2017
SCN1a 2q24.3 Epilepsy
Vs. 07
14-05-2011
SLC2A1 1p34.2 Glut1 deficiency syndrome
P138-B1 Vs. 08 02-10-2011 SLC2A1 1p34.2 Glut1 deficiency syndrome
P138-B2 Vs. 10 20-12-2012 SLC2A1 1p34.2 Glut1 deficiency syndrome
P138-C1 Vs. 11 13-05-2015 SLC2A1 1p34.2 Glut1 deficiency syndrome
P138-C1 Vs. 12 20-01-2017 SLC2A1 1p34.2 Glut1 deficiency syndrome
Vs. 06
10-06-2008
DEF, 8q22, 8q23, Defensin
Vs. 07
14-04-2009
DEF, 8q22, 8q23, Defensin